An investigation for investors in Align The Clorox Co (NYSE:CLX) shares over potential securities laws violations was announced and NYSE:CLX stockholders should contact the Shareholders Foundation at firstname.lastname@example.org
San Diego, CA -- (SBWIRE) -- 06/11/2014 -- An investigation on behalf of investors of The Clorox Co (NYSE:CLX) shares over potential securities laws violations in connection certain financial statements was announced.
If you purchased shares of The Clorox Co (NYSE:CLX), you have certain options and you should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of The Clorox Co (NYSE:CLX) concerning whether a series of statements regarding The Clorox Co’s business, its prospects and its operations were materially false and misleading at the time they were made.
On May 30, 2014, a report was published that, "Federal authorities are examining a series of well-timed trades made by golfer Phil Mickelson and Las Vegas gambler William T. Walters," on potentially nonpublic information provided by activist investor Carl Icahn, in the days leading up to Mr.Icahn's tender offer announcement for the Clorox Co on July 15, 2011. On the news of Icahn's $76.50 per share offer announcement, The Clorox Co options and shares increased and closed at$74.55 per share, up 8.9%, on July 15, 2011.
The Clorox Co reported that its Total Revenue rose from over $5.46 billion for the 12 months period that ended on June 30, 2012 to over $5.62 billion for the 12 months period that ended on June 30, 2013, and that its respective Net Income grew from $541.00 million to $572.00 million. Shares of The Clorox Co (NYSE:CLX) grew from $63.97 per share in late 2011 to as high as $95.78 per share in late 2013.
On June 9, 2014, NYSE:CLX closed at $92.66 per share.
Those who purchased shares of The Clorox Co (NYSE:CLX), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego